A central question in protein molecular evolution is whether an amino acid that occurs at a given site makes an independent contribution to fitness or whether its contribution depends on other amino acid sites in the protein sequence, a phenomenon known as intragenic epistasis. In the absence of intragenic epistasis, natural selection acts on a protein mutation independent of its genetic background, and the experimentally determined fitness for a mutation should be the same across all genetic backgrounds. We tested this hypothesis by using site-directed mutagenesis to introduce a well-characterized deleterious single amino acid substitution in 56 different hepatitis C virus NS3 protease variants. The catalytic efficiency of the mutated proteases was determined and compared with the corresponding wildtype protein. Fitness effects ranged from lethality to significantly beneficial. Although primarily deleterious and lethal effects were observed (41 and 5 out of 56 tested variants, respectively), deleterious effects ranged from near neutral (À26.7% reduction of fitness) to near lethal (À98.5%). Our findings demonstrate that the introduced amino acid substitution has different fitness effects in different protein variants and provide independent support for the relevant role of intragenic epistasis in protein evolution.
Introduction
The main factors that determine short-and long-term protein molecular evolution remain controversial. One of these factors is epistasis. An amino acid substitution that is neutral or beneficial in one genetic context may be deleterious in another. The fitness effect of one mutation depending on the genetic background at other loci is called epistasis. Although there is an extensive body of both theoretical and empirical work in epistasis (reviewed in Weinreich et al. 2005; Bloom et al. 2007; Dean and Thornton 2007; Kouyos et al. 2007; Poelwijk et al. 2007; de Visser et al. 2011; Szendro et al. 2013) , the fraction of amino acid substitutions that occur in one protein variant and is acceptable in another homologous protein background is unknown. Recently, epistasis has been argued to be pervasive throughout protein evolution because the observed ratio between the per-site rates of nonsynonymous and synonymous substitutions (dN/dS) is much lower than expected in the absence of epistasis (Breen et al. 2012) . Similarly, studies characterizing the in vitro fitness of clinical isolates of human immunodeficiency virus (HIV) have reported that the fitness landscape of HIV protease and reverse transcriptase proteins is characterized by strong epistasis (Bonhoeffer et al. 2004; Hinkley et al. 2011) . However, other studies performed with previous data sets and different model approaches found no direct evidence of epistasis (Wang et al. 2006; McCandlish et al. 2013 ). These results required further work in order to substantiate the role of epistasis in protein evolution.
Despite its fundamental role in evolutionary biology, little data are available on empirical intragenic epistasis. Although intergenic epistasis has been explored extensively in eukaryotes, bacteria, and viruses, studies of intragenic epistatic interactions have been insufficient (Elena et al. 2010; de Visser et al. 2011) . Using HIV protease as a model system, we previously generated 114 genotypes, each carrying pairs of nucleotide substitution mutations and determined their separate and combined deleterious effects on fitness in order to systematically determine intragenic epistatic interactions (Parera et al. , 2009 . Although several pairs exhibited significant interactions for fitness, including positive and negative epistasis, the average epistatic effect was not significantly different from zero. However, a large proportion of pairs (40%) created synthetic lethals, which may have biased the results. Kryazhimskiy et al. (2011) developed a novel statistical method for detecting positive epistasis between pairs of sites in a protein based on the observed temporal patterns of sequence evolution. By applying this method to the influenza A virus surface proteins hemagglutinin and neuraminidase, substantial epistasis was detected. More recently, Schenk et al. (2013) found a high incidence of sign epistasis by quantifying epistasis in two sets of four beneficial mutations in the antibiotic resistance enzyme TEM-1 b-lactamase. Sign epistasis means that the sign of the fitness effect of a mutation is under epistatic control; thus, such a mutation is beneficial on some genetic backgrounds and deleterious on others (Weinreich et al. 2005) . Sign epistasis has a strong impact on natural selection. It may render mutational pathways effectively inaccessible or open up new pathways. Intragenic fitness epistatic interactions have been also described in the malarial parasite Plasmodium falciparum dihydrofolate reductase (Lozovsky et al. 2009; Brown et al. 2010) , HIV exterior envelope glycoprotein (gp120) (da Silva et al. (Gong et al. 2013) , Escherichia coli isopropylmalate dehydrogenase, triosephosphate isomerase, and phosphoglycerate kinase (Lunzer et al. 2005; Merlo et al. 2007; Wellner et al. 2013) , modern game bird lysozymes (Malcolm et al. 1990 ), rat and swine fever virus DNA polymerases (O'Maille et al. 2002) , and vertebrate glucocorticoid receptor (Ortlund et al. 2007; Bridgham et al. 2009 ).
Because natural selection acts on a mutation independent of genetic background in the absence of epistasis, a straightforward approach to studying intragenic epistasis is to measure the fitness effect of the exact same amino acid mutation in different genotypes of the protein. Under the null hypothesis, the experimentally determined fitness for a mutation should be the same across all genetic backgrounds. Here, we explored whether the fitness effects of an amino acid substitution depends on the genetic context of the protein in which it occurs. Our model system was the hepatitis C virus (HCV) NS3 protease, an enzyme that is essential for viral polyprotein processing and HCV evasion of innate antiviral immunity through viral NS3 protease cleavage of human mitochondrial antiviral signaling (MAVS) protein. HCV was chosen for this study because, like other RNA viruses, it is able to generate a complex distribution of genetically related variants with a broad range of different fitness values (Franco et al. 2007; Aparicio et al. 2011) . Another interesting aspect of this protease is that it can coevolve with virus cleavage sites, but it must be capable of processing the conserved host MAVS protein in order to evade innate cellular defences (Lemon 2010) . This feature of the NS3 protease facilitates its experimental characterization. A set of genetically related viral proteases with a broad range of different catalytic activities was chosen for this study Nevot et al. 2014) . In this set of proteases, the A156T substitution was introduced by site-directed mutagenesis. The A156T substitution confers resistance to HCV NS3 protease inhibitors and has been observed in infected individuals that failed this drug therapy (Pawlotsky 2011) . This substitution alters the affinity of the drug for the enzyme's catalytic site, thereby attenuating its inhibitory activity and generally reducing the catalytic efficiency of the protease. Thus, A156T variants are rarely detected in proteases that have never been exposed to protease inhibitors. The introduction of this substitution in different HCV NS3 proteases resulted in a broad range of different fitness effects, which demonstrate the presence of strong epistatic interactions in this protein.
Results
One prominent feature of HCV is its genetic variability. HCV populations have been shown to consist of a distribution of mutant genomes (Martell et al. 1992; Mas et al. 2010) . In order to obtain a set of genetically diverse and enzymatically robust HCV NS3 proteases from replication-competent viruses, 1895 NS3 protease clones (average 34 clones per individual) were isolated and sequenced from 56 individuals infected with HCV of genotype 1 (41 of subtype 1a and 15 of subtype 1b) Nevot et al. 2014 ). The most abundant variant from each infected individual was identified and selected for further work (supplementary fig. S1 , Supplementary Material online). Using site-directed mutagenesis, we introduced the A156T substitution in the dominant NS3 protease variant of each individual. The catalytic efficiency of the 56 wild-type and 56 mutated proteases was assayed via MAVS cleavage using a bacteriophage genetic screen. The enzymatic activities of variant proteases were evaluated by engineering the MAVS cleavage site into the cI repressor. The enzymatic activity was related to the activity of a protease variant carrying the lethal substitution S139A. The S139 residue is part of the catalytic triad of the enzyme. As we have previously demonstrated (Franco et al. 2007; Aparicio et al. 2011; Parera et al. 2012) , the expression of the HCV NS3 protease resulted in cleavage of the lambda cI repressor with MAVS cleavage site ( fig. 1 ). Expression of an NS3 protease that included a substitution in catalytic residue S139 completely abolished the cleavage of lambda cI repressor. Figure 2 shows the catalytic efficiency of the 112 proteases analyzed for MAVS protein cleavage. The distribution of log enzymatic activity values for wild-type proteases ranged over two orders of magnitude, which likely reflects the fact that mutations present in the different protease variants affected their catalytic efficiency. The fitness for each of the 56 proteases carrying the A156T substitution was compared with the corresponding wild-type variant using the unpaired t-test, and each mutated protease was subsequently classified into one of four categories: lethal, deleterious, neutral, or beneficial (table 1). The mean fitness effect for the 56 mutated proteases was À57.6%. No differences were found between the mean fitness effect of subtype 1a and 1b proteases (À59.1% for subtype 1a and À53.7% for subtype 1b; P = 0.7179, unpaired t-test). If intragenic epistasis is absent, we would expect to detect the same fitness effect across all genetic backgrounds. Instead, a complex distribution of different fitness effects was observed with the different protease variants, demonstrating strong intragenic epistatic interactions within HCV NS3 protease. A broad range of relative fitness effects was observed in the 56 mutated proteases (from À100% to 97.4%; fig. 3 ). The distribution of the relative fitness of the 56 mutated proteases The catalytic efficiency of four proteases (H, H-A156T, 41 and 41-A156T) from individuals H and 41 were tested in the absence or presence of an NS3 protease inhibitor (danoprevir). Expression of the HCV NS3 proteases resulted in cleavage of the lambda cI repressor with MAVS cleavage site. Expression of the protease was induced with IPTG for 3 h. The lambda cI repressor with MAVS cleavage site was not cleaved by an NS3 protease that included a substitution in catalytic residue S139A. Similarly, different catalytic efficiencies were observed with different proteases.
was highly skewed toward negative values (g1 = 1.648; fig. 3) ; consequently, the median (À77.18%) was less than the mean. The distribution was also highly leptokurtic (g2 = 2.118). Deleterious effects ranged from near neutral (À26.7% reduction of fitness) to near lethal (À98.5%). Consequently, three groups of mutated proteases with significantly different fitness were distinguished within the group of deleterious variants: a highly deleterious group with fitness effects below À90%, a second group with fitness effects between À90% and À70%, and a third group with fitness effects between À70% and neutral ( fig. 3) .
As expected, in a control experiment with two HCV NS3 protease inhibitors, 25a and danoprevir, no significant inhibition was observed when the A156T-mutated proteases were assayed ( fig. 4) , whereas wild-type proteases were significantly inhibited. This experiment confirmed the protease inhibitorresistant phenotype of proteases carrying the A156T mutation.
In order to correlate fitness effects and sequence background, a phylogeny fitness landscape map was constructed by correlating the phylogenetic relationships and relative catalytic efficiencies of the 56 mutated proteases using the median-joining network method (Bandelt et al. 1999) . Two different landscapes were obtained, one for subtype 1a sequences (n = 41) and the other for subtype 1b sequences (n = 15; fig. 5 ). A complex scenario was found within the subtype 1a landscape ( fig. 5A ). Beneficial and neutral variants formed two clusters (proteases 31, 36, 37, and 39, and proteases 2, F, and H, respectively). Within these two clusters, protease variants were one or two amino acids different from each other, indicating their phylogenetic relationships. However, some beneficial and neutral variants were also one amino acid different from deleterious or highly deleterious variants, suggesting that only one amino acid substitution can change the protease fate. Due to the fewer number of variants, a simpler scenario was observed within subtype 1b amino acid sequences ( fig. 5B ). Again, beneficial or neutral variants clustered together (proteases 45, 51, and 59), indicating their phylogenetic relationship. Next, the relationship between the relative fitness of mutated proteases and sequence conservation was investigated. The MAVS-cleavage activity of the protease was compared with how conserved the wild-type protease amino acid sequences were relative to amino acid frequencies in a reference database including 307 sequences of subtype 1a and 328 sequences of subtype 1b protease (Kuiken et al. 2005) . A positive tendency was found between the conservation of sequences relative to the site-specific database frequencies and their relative fitness, suggesting that selected or random mutations accumulating through virus evolution may affect protease fitness. However, this tendency was not significant (r = 0.0689, P = 0.6138, Spearman).
Discussion
Prior work documented that intragenic epistatic interactions may affect the majority of all amino acid substitutions in proteins (Bonhoeffer et al. 2004; Hinkley et al. 2011; Kryazhimskiy et al. 2011; Breen et al. 2012; Schenk et al. 2013 ). However, experiments have been limited. In this study, we tested the extent to which the effect of one amino acid mutation depends on the presence or absence of one or more additional amino acid mutations in the same protein.
We found that the substitution of an amino acid has different fitness effects in different protein variants. Our findings provide evidence for the relevant role of intragenic epistasis in protein evolution and indicate the presence of strong intragenic epistatic interactions within a protein. A mutation being deleterious to one protease variant but benign or beneficial to another variant within the same population may be more common than previously thought. Only 6 backgrounds out of 56 tested here did not exhibit significant epistasis. In addition, the broad range of relative fitness effects observed in our study confirms the ruggedness of protein fitness landscapes. Epistasis is a property of protein fitness landscapes; an amino acid at a specific site confers high fitness in one genetic background and low fitness in another. If such situations are common, the protein fitness landscape can be described as rugged (Weinreich et al. 2005 (Weinreich et al. , 2006 Dean and Thornton 2007; Poelwijk et al. 2007; Szendro et al. 2013) . Compensatory interactions between different sites in the protein structure are well documented, and the phenomenon is expected to contribute substantially to the ruggedness of protein fitness landscapes (Aita and Husimi 1996; Ortlund et al. 2007; Povolotskaya and Kondrashov 2010) . Indeed, sign epistasis produces rugged landscapes in which multiple patches of sequence space can be isolated by genetic intermediates of low fitness. In the evolution of vertebrate glucocorticoid receptor (Bridgham et al. 2009 ), bacterial beta-lactamase (Weinreich et al. 2006) , bacterial isopropylmalate dehydrogenase (Lunzer et al. 2005) , and phosphoglycerate kinase (Wellner et al. 2013) , sign epistasis blocks many adaptive walks through sequence space, so that mutations must be acquired in a particular order to avoid deleterious intermediates. Our study indicates that the fitness landscape of HCV NS3 protease cannot be described without taking into account sign epistatic interactions among the protein residues, which can reflect nontrivial compensatory interactions.
Here, we investigated the intragenic fitness effects of a substitution that confers resistance to HCV NS3 protease inhibitors. Similar to what was found previously with HIV and influenza resistance to antivirals (Hinkley et al. 2011; Kryazhimskiy et al. 2011) , the ability to predict the precise succession of genetic events leading to the development of HCV NS3 protease inhibitor-resistant strains during treatment remains limited (Pawlotsky 2011) . Our results show that this is in part due to the widespread epistasis observed in the NS3 protease. The epistasis observed here indicates that some NS3 protease backgrounds may be more prone to develop protease inhibitor resistance than others. The low prevalence of the NS3 A156T substitution in individuals naive to NS3 protease inhibitors is in agreement with our results in which the distribution of the relative fitness of the 56 mutated proteases carrying the A156T substitution was highly skewed toward negative values. However, this mutation may be neutral or beneficial in some contexts, which may be why the A156T substitution is found in some HCV-infected individuals naive to NS3 protease inhibitors (Lopez-Labrador et al. 2008; Franco et al. 2011) . A complex scenario was found when a fitness landscape map was constructed for the 56 mutated NS3 proteases. Although beneficial and neutral variants formed phylogenetic clusters, the influences of protein structure on epistasis are not straightforward. Further studies should investigate whether epistatic sites compensate for NS3 protein stability, conformation, or interaction with other viral or host proteins.
Despite their structural simplicity, reduced size, and high mutation rates, the genomes of RNA viruses show complex patterns of epistatic interactions between and within genes (reviewed in Elena et al. 2010) . The presence of epistatic interactions and the high frequency of recurrent mutations contribute to generate a highly complex interference dynamics (Cabanillas et al. 2013) . Epistatic interactions may affect the existence of sex and recombination in some RNA viruses Elena et al. 2010) , as well as the mechanisms of RNA virus mutational robustness . Our findings support the notion that epistatic interactions among mutations are very frequent in RNA viruses Kryazhimskiy et al. 2011 ) and can influence their adaptive trajectories.
Major questions in evolutionary biology are unresolved, including the role of epistasis in shaping protein evolutionary pathways and outcomes (Harms and Thornton 2013) . In particular, debate continues about the relative role of epistasis in determining protein fitness (McCandlish et al. 2013) . Here, we show that intragenic epistasis may be crucial for determining protein fitness. Moreover, intragenic epistasis may be also an intrinsic property of single locus evolution. Our approach provides a simple tool for constructing protein fitness landscapes and to explore the prevalence of intragenic epistasis in different proteins and organisms. Further work should consider how intragenic epistasis influences protein evolutionary outcomes.
Materials and Methods

Recovery and Analysis of HCV NS3 Protease Sequences
The individual NS3 protease clones were generated by reverse transcription (RT)-PCR amplification of HCV genomic RNA extracted from the plasma of 56 different infected individuals and ulterior PCR cloning into pBSK (Agilent Technologies) to generate a b-gal-HCVNS3 2-181/421-34 protease fusion protein (pHCVNS3 2-181/421-34 protease). RT-PCR conditions and oligonucleotides were described previously, as well as PCR digestion, ligation, sequencing, and cloning protocols (Franco et al. 2007; Aparicio et al. 2011; Parera et al. 2012) . After sequencing the 1895 HCV NS3 protease plasmid clones, the most abundant HCV NS3 protease variants from each of the 56 infected individuals was identified and selected. The NS3 protease substitution A156T was then introduced in the 56 selected plasmids using the QuikChange II Site-Directed Mutagenesis Kit (Agilent Technologies) and following the manufacturer's instructions.
Genetic Screen for Determining the Catalytic Efficiency of HCV NS3 Proteases
The catalytic efficiency of the different wild-type and mutated HCV NS3 proteases was determined using a previously described bacteriophage lambda ()-based genetic screen Franco et al. 2007; Parera et al. 2012) . A plasmid was constructed (pcI.MAVScro) with the MAVS NS3/4A protease cleavage site, EREVPC/HRPS, as described previously . Escherichia coli JM109 cells containing plasmid pcI.MAVScro were then transformed with plasmid pHCVNS3 2-181/421-34 protease. Transformed cells were grown overnight at 30 C in the presence of 0.2% maltose, 12.5 mg/ml of tetracycline, and 20 mg/ml of ampicillin, harvested by centrifugation, and resuspended to an optical density at 600 nm of 2.0/ml in 10 mM MgSO 4 . To induce the expression of HCVNS3 2-181/421-34 protease, cells (20 ml) were incubated in 100 ml of Luria-Bertani (LB) medium containing 12.5 mg/ml tetracycline, 20 mg/ml ampicillin, 0.2% maltose, 10 mM MgSO 4 , and 0.1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) for 1 h. The cell cultures were then infected with 10 5 PFU of phage. After 3 h at 37 C, the titer of the resulting phage was determined by coplating the cultures with 200 ml of E. coli XL-1 Blue cells (adjusted to an optical density at 600 nm of 2.0/ml in 10 mM MgSO 4 ) on LB plates using 3 ml of top agar containing 12.5 mg tetracycline/ml, 0.2% maltose, and 0.1 mM IPTG. After incubation at 37 C for 6 h, the resulting phage plaques were counted in order to score growth. In the experiments in which E. coli cells expressed master wild-type protease sequences from study samples, phage replicated up to 2.19 log (range 0.4-2.19)-fold more efficiently than in cells that expressed a construct with a patient protease variant carrying the inactivating substitution S139A. Importantly, wild-type proteases 2 and L, which had different nucleotide sequences but the same amino acid sequence, had an indistinguishable catalytic efficiency (0.74 ± 0.09 and 0.84 ± 0.06, respectively, P = 0.4079, unpaired t-test, fig. 1 ). Moreover, the introduction of the A156T substitution in these two proteins had the same effect on the catalytic efficiency of the protease. Macrocyclic HCV NS3 protease inhibitor 25a (Liverton et al. 2008 ) was kindly provided by Merck, Sharp, and Dohme. Danoprevir was purchased from Selleck Chemicals (Houston, TX).
Western blot was performed as previously described (Parera et al. 2012) . Briefly, E. coli JM109 cells containing plasmid pcI.MAVScro was transformed with the plasmid expressing the corresponding protease. Transformed cells were then grown overnight at 30 C in the presence of 0.2% maltose, 12.5 mg/ml tetracycline, and 20 mg/ml ampicillin; harvested by centrifugation; and resuspended to an optical density at 600 nm of 2.0/ml in 10 mM MgSO 4 . To induce expression of the protease, 200 ml of cells were incubated in 1 ml of LB medium containing 12.5 mg/ml tetracycline, 20 mg/ml ampicillin, 0.2% maltose, 10 mM MgSO 4 , and 0.1 mM IPTG for 3 h. The ODs of the cultures after 3 h (in the presence of IPTG) were measured to assure that equivalent amounts of total cell protein were blotted. No significant differences were observed when the ODs of the different cultures were compared, suggesting that the expression of the NS3/4A proteases did not affect the growth of the bacteria. Cultures were lysed in sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis sample buffer, resolved in 12% gradient SDS-polyacrylamide gels (Invitrogen), transferred to nitrocellulose membranes, and blocked in phosphate-buffered saline-0.1% Tween 20-10% nonfat dry milk. For immunochemical detection of the lambda repressor, membranes were subsequently incubated with rabbit serum containing polyclonal anti-cI antibodies (anti-cI sera; Life Technologies). Bound antibodies were visualized with peroxidase-linked anti-rabbit antibody HRP-linked IgG (Cell Signaling Technology) and the SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific).
Phylogeny Fitness Landscape Map
The phylogenetic relationships and relative enzymatic activities of the 56 different A156T-mutated HCV NS3 proteases were plotted together using the median-joining method implemented in NETWORK v 4.1.0.9 software (Bandelt et al. 1999) as described previously (Franco et al. 2007 ).
Statistical Analysis
Statistical analyses were performed using GraphPad Prism version 4.00 for Windows (GraphPad).
Supplementary Material
Supplementary figure S1 is available at Molecular Biology and Evolution online (http://www.mbe.oxfordjournals.org/).
